Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Pharmaceuticals			225.14M	255.40M	285.14M	284.79M	324.91M
Pharmaceuticals Growth			-11.85%	-10.43%	0.12%	-12.35%	15.96%
Unallocated Other Business			350.04K	70.32K	514.50K	1.53M	-
Unallocated Other Business Growth			397.79%	-86.33%	-66.37%	-	-
Total			225.49M	255.47M	285.66M	286.32M	324.91M
Total Growth			-11.73%	-10.57%	-0.23%	-11.88%	15.96%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China			225.49M	255.47M	285.66M	286.32M	324.91M
China Growth			-11.73%	-10.57%	-0.23%	-11.88%	15.96%
Total			225.49M	255.47M	285.66M	286.32M	324.91M
Total Growth			-11.73%	-10.57%	-0.23%	-11.88%	15.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error